amoxicillin
Commercial- Indications
- Bacterial infections
Company intelligence / Profile preview
Daewoong Bio
Ansung, Gyeonggi-do, South Koreadaewoongchemical.com ↗
- Ownership
- Private
- Employees
- ~346
- Development stage
- Commercial
01
Overview
Daewoong Bio is a leading South Korean manufacturer of active pharmaceutical ingredients (APIs), specializing in antibiotics such as cephalosporins and carbapenems, as well as other general APIs like bile acids. The company operates cGMP-compliant facilities and serves both domestic and international markets. It has expanded into formulations including prescription drugs, OTC products, and some bio-based pharmaceuticals. In 2018, revenue reached $260 million with approximately 346 employees. Recent regulatory issues have affected its participation in China’s national drug procurement program until January 2026 due to compliance concerns regarding cephalosporin production.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Contract Manufacturing Organization
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Technology transfer from Roche Korea plant acquisitionLilly Korea plant acquisition for manufacturing expansion
Beyond the preview
Go deeper on Daewoong Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daewoong Bio.